Live Breaking News & Updates on Platinum Based Regimen

Stay updated with breaking news from Platinum based regimen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Treatment Choices for Recurrent dMMR Endometrial Cancer

Exploring treatment options for patients with recurrent mismatch repair deficient endometrial cancer, including the choice between single-agent checkpoint inhibitors and chemo-immunotherapy combinations, with insights from GARNET and KEYNOTE-158 studies. ....

Optimizing Therapy , Endometrial Cancer , Recent Data Highlights , Recurrent Endometrial Cancer , Mismatch Repair Deficiency , Treatment Recommendations , Checkpoint Inhibitors , Platinum Based Regimen , Response Rate , Duration Of Response , Keynote 158 , Overall Survival , Treatment Options , Lenvatinib Pembrolizumab , Second Line Treatment , Treatment Impact , Overall Survival Data ,

Chronic Challenges in Endometrial Cancer: Recurrence and Second-Line Therapy

Experts Ritu Salani, MD, MBA, and Bhavana Pothuri, MD, discuss the prevalence of patients with recurrent endometrial cancer, challenges in responding to chemotherapy, and the potential for improved treatment options in the second-line setting. ....

Bhavana Pothuri , Optimizing Therapy , Endometrial Cancer , Recent Data Highlights , Second Line Therapy , Ritu Salani , Recurrent Cancer , Partial Disease , Persistent Disease , Refractory Patients , Mismatch Repair Deficient , Platinum Based Regimen , Disease Free Interval , Treatment Challenges , Pre Treatment , Endometrial Cancer Recurrence ,